Inactive Instrument

All News Akcea Therapeutics, Inc.

Equities

AKCA

US00972L1070

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

Aspen Neuroscience, Inc. Appoints Lisa Johnson-Pratt as Senior Vice President, Therapeutic Program Lead	Feb. 14	CI
Mersana Therapeutics, Inc. Announces Carla Poulson as Chief Human Resources Officer	21-01-19	CI
Ionis Pharmaceuticals : Akcea Therapeutics - WAYLIVRA, the first and only therapy for familial chylomicronaemia syndrome, to be available on the NHS in Scotland	20-11-10	AQ
Ionis Pharmaceuticals : and Akcea Recognize FCS Awareness Day with Global Community Efforts to Celebrate Unsung Heroes	20-11-09	AQ
Akcea Therapeutics Announces Scottish Medicines Consortium Enabled Access to Volanesorsen on the National Health Service in Scotland for the Treatment of Familial Chylomicronaemia Syndrome	20-11-09	CI
IONIS PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	20-11-04	AQ
Ionis Pharmaceuticals : and Akcea announce that Pfizer has initiated a Phase 2b clinical study of vupanorsen	20-11-04	AQ
Ionis Pharmaceuticals : and Akcea win prestigious Prix Galien Award for TEGSEDI as Best Biotechnology Product	20-11-02	AQ
Ionis Pharmaceuticals : completes acquisition of Akcea Therapeutics	20-10-13	AQ
AKCEA THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	20-10-13	AQ
Akcea Therapeutics, Inc. Announces Management Changes	20-10-13	CI
IONIS PHARMACEUTICALS INC : Completion of Acquisition or Disposition of Assets, Other Events, Financial Statements and Exhibits (form 8-K)	20-10-13	AQ
Akcea Therapeutics : Ionis Pharmaceuticals completes acquisition of Akcea Therapeutics	20-10-12	PR
Akcea Therapeutics, Inc.(NasdaqGS:AKCA) dropped from S&P TMI Index	20-10-12	CI
Akcea Therapeutics, Inc.(NasdaqGS:AKCA) dropped from S&P Global BMI Index	20-10-12	CI
Akcea Therapeutics, Inc.(NasdaqGM:AKCA) dropped from Russell Small Cap Comp Value Index	20-10-12	CI
Akcea Therapeutics, Inc.(NasdaqGM:AKCA) dropped from Russell 2000 Value Index	20-10-12	CI
Akcea Therapeutics, Inc.(NasdaqGM:AKCA) dropped from Russell 2500 Value Index	20-10-12	CI
Akcea Therapeutics, Inc.(NasdaqGM:AKCA) dropped from Russell 3000 Value Index	20-10-12	CI
Akcea Therapeutics, Inc.(NasdaqGM:AKCA) dropped from Russell 2000 Value-Dynamic Index	20-10-12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Akcea Therapeutics, Inc.

Equities

AKCA

US00972L1070

All News

Filters